Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Cutaneous Leishmaniasis
NCT01464242Phase 3Completed
- Sponsor
- CIDEIM
- Start
- Nov 2011
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pentoxifylline in cutaneous leishmaniasis (CL), sponsored by CIDEIM. Started Nov 2011; status: completed.
02
Drugs
pentoxifylline
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT01464242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01464242.